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chimpanzees to humans may be 
possible (or vice versa), they say. 
One major impediment may be the 
structure of surface molecules key 
to viral transmission. The fact that 
this transmission has not happened 
repeatedly may reflect the specificity 
of the parasite-binding proteins. “In 
this regard, it is interesting that a major 
barrier limiting cross transmission of 
avian influenza into humans (and vice 
versa) is due to differences in sialic 
acid linkage binding specificity,” the 
authors write. In this case, it is the 
relative preference for human and 
avian virus haemagglutinins binding 
two specific sialic acids, respectively, 
on epithelial cells in target tissues.
This is another instance in which a 
human-specific change in sialic acid 
biology is relevant to infectious disease 
transmission, as chimpanzees and 
other great apes do not express human 
upper airway epithelial sialic acid 
targets for human influenza viruses, 
they say.
Growing insights into the molecular 
details of malaria genetics and host 
molecules are likely to be increasingly 
important in developing new strategies 
to tackle this disease. Each year 
300–500 million episodes of malaria 
infection occur which cause up to  
2.5 million deaths, mostly in children. 
Non-fatal malaria imposes an 
enormous economic burden of illness 
with a major impact on infected 
communities. The global cost of 
malaria in terms of lost productivity 
and medical care exceeds $1.7 billion 
each year, according to the US 
organisation USAID. “Available 
methods to prevent and treat malaria 
are inadequate — the mosquitoes that 
transmit the disease have become 
resistant to insecticides, and the 
parasites have become resistant to 
drugs. New technologies are urgently 
needed. Economic analyses have 
concluded that the benefits from 
an effective malaria vaccine would 
far outweigh the anticipated cost 
of research and development and 
program implementation.”
The researchers in this latest 
report believe the discovery of the 
chimpanzee variants of the parasite 
may be of benefit in developing 
vaccines. The P. reichenowi 
parasites show a greatly diminished 
pathogenicity in chimps compared 
with P. falciparum in humans. Vaccines 
based on the chimpanzee parasites 
may be naturally attenuated in a way 
that cowpox proved so effective in 
inoculation against human smallpox. 
The search for new, effective 
treatments for malaria remains one of 
the top priorities for medical research.
New links: The human malaria P. falciparum appears to have jumped from a related species 
infecting chimpanzees. (Photo: Sinclair Stammers/Science Photo Library.)A tunnel of 3.4 km length and 5.4 m 
diameter is soon to be dug between 
Hamburg and the nearby village of 
Schenefeld. While its dimensions 
are reminiscent of a tunnel for 
underground rail systems, the 
passengers in this tube will only be 
electrons travelling from Hamburg’s 
DESY research centre towards new 
facilities to be built at Hamburg-
Osdorf and Schenefeld. At Osdorf, 
strong magnetic fields will push these 
electrons sideways at rapid intervals, 
causing them to emit powerful X-rays 
in sharply focused pulses, which will 
then travel on to Schenefeld.
Based on theoretical predictions 
and observations made with a 
smaller prototype built at DESY, 
scientists involved with the European 
X-ray Free-Electron Laser (XFEL) 
facility expect that they can push 
the wavelength limits of laser light 
deep into the X-ray band of the 
electromagnetic spectrum, possibly 
as low as 0.1 nm. Researchers using 
one of the ten experimental stations 
at Schenefeld will then have access to 
coherent X-rays much more powerful 
A signature from Vladimir Putin has 
finally secured the construction of 
a revolutionary new European X-ray 




Current Biology Vol 19 No 16
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directed through an undulator. (Photo: XFEL.)than synchrotron radiation and in 
much shorter pulses. 
For structural biologists this means 
that they no longer have to rely on 
crystals, which have so far been a 
notorious bottleneck in structural 
research. Instead, they will be able 
to study X-ray diffraction of single 
molecules and obtain complete 
datasets in fractions of a second. 
“A three-dimensional data set could 
be assembled from such patterns 
when copies of a reproducible 
sample are exposed to the beam 
one by one,” biophysicist Janos 
Hajdu from the University of Uppsala, 
Sweden, explains. “The over-
sampled diffraction pattern permits 
phase retrieval and hence structure 
determination. The challenges in 
carrying out such an experiment 
are formidable, and engage an 
interdisciplinary approach drawing 
upon structural biology, atomic 
and plasma physics, mathematics, 
statistics, and X-ray laser physics.” 
The short pulse length also implies 
that molecular changes can be 
studied in real time. 
Other XFEL applications will be in 
materials science, chemical kinetics and catalysis, and in X-ray physics. 
X- ray lasers are also being developed 
in the US (Stanford) and in Japan.  
In April, the LCLS facility at Stanford 
reported lasing at wavelengths down  
to 0.15 nm. However, only the European 
facility will use superconducting 
accelerator technology. This will be an 
advantage as it will be able to produce 
30,000 X-ray pulses per second,  
two orders of magnitude more  
than the other facilities. 
Scientists at DESY originally 
hatched the laser project as a spin-off 
from the planned linear collider TESLA 
(later merged into the International 
Linear Collider project still awaiting 
the go-ahead), and submitted their 
plans to the German government. In 
2003, the government launched the 
project as a European collaboration, 
with Germany committed to paying 
60 per cent of the construction cost 
(estimated at just over a billion euros 
at 2005 prices) and 40 per cent  
of the running cost. 
Since then, eleven other 
European countries have joined the 
collaboration, as well as China and 
Russia. On July 23, Russian prime 
minister Vladimir Putin signed a government order committing Russia 
to a contribution of 250 million euros 
towards the construction cost, which 
essentially secured the financing 
of the project. Building work on the 
tunnel access facilities at DESY, and 
in Osdorf and Schenefeld has already 
begun. Excavation of the tunnel is due 
to start in October. Thus the project 
is now on track to start experimental 
work in 2014.
“As a result of formal approval by the 
Russian cabinet meeting, all conditions 
are satisfied for the signature of the 
intergovernmental convention later 
this year. The project is well under 
way (major civil construction started 
already in January), but the official 
creation of the European XFEL 
company will accelerate recruitment of 
scientific personnel and ensure timely 
allocation of project funds throughout 
the construction phase. Everything is 
according to plan for the first users 
coming in 2015,” says Massimo 
Altarelli, leader of the European  
XFEL project team.
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